Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation
Kim E. DzoboArjen CupidoBarend M. MolLotte C.A. StiekemaMiranda VerslootMaaike WinkelmeijerJorge PeterAnne-Marije PennekampStefan HavikFrédéric M. VazMichel van WeeghelKoen H.M. PrangeJohannes H.M. LevelsMenno P.J. de WintherSotirios TsimikasAlbert K. GroenErik S.G. StroesDominique P.V. de KleijnJeffrey KroonDepartments of Experimental Vascular Medicine,Amsterdam UMC,University of Amsterdam,Amsterdam Cardiovascular Sciences,the Netherlands. (K.E.D.,M.V.,M.W.,J.P.,A.-M.P.,S.H.,J.H.M.L.,A.K.G.,J.K.)Vascular Medicine,Amsterdam UMC,University of Amsterdam,Amsterdam Cardiovascular Sciences,the Netherlands. (A.C.,L.C.A.S.,E.S.G.S.)Amsterdam Cardiovascular Sciences,Atherosclerosis and Ischemic Syndromes,the Netherlands (K.E.D.,M.V.,J.K.).Department of Vascular Surgery,University Medical Centre Utrecht,the Netherlands (B.M.M.,D.P.V.d.K.).Core Facility Metabolomics,Amsterdam UMC,University of Amsterdam,the Netherlands. (F.M.V.,M.v.W.)Department of Medical Biochemistry,Amsterdam Infection and Immunity,Amsterdam UMC,University of Amsterdam,the Netherlands. (K.H.M.P.,M.P.J.d.W.)Division of Cardiovascular Medicine,Sulpizio Cardiovascular Center,University of California San Diego,La Jolla (S.T.).Laboratory of Angiogenesis and Vascular Metabolism,VIB-KU Leuven Center for Cancer Biology,VIB,Belgium (J.K.).Laboratory of Angiogenesis and Vascular Metabolism,Department of Oncology,KU Leuven and Leuven Cancer Institute,Belgium (J.K.).
DOI: https://doi.org/10.1161/atvbaha.123.319937
2024-01-26
Arteriosclerosis Thrombosis and Vascular Biology
Abstract:Arteriosclerosis, Thrombosis, and Vascular Biology, Ahead of Print. BACKGROUND:Oxidized phospholipids play a key role in the atherogenic potential of lipoprotein(a; Lp[a]); however, Lp(a) is a complex particle that warrants research into additional proinflammatory mediators. We hypothesized that additional Lp(a)-associated lipids contribute to the atherogenicity of Lp(a).METHODS:Untargeted lipidomics was performed on plasma and isolated lipoprotein fractions. The atherogenicity of the observed Lp(a)-associated lipids was tested ex vivo in primary human monocytes by RNA sequencing, ELISA, Western blot, and transendothelial migratory assays. Using immunofluorescence staining and single-cell RNA sequencing, the phenotype of macrophages was investigated in human atherosclerotic lesions.RESULTS:Compared with healthy individuals with low/normal Lp(a) levels (median, 7 mg/dL [18 nmol/L]; n=13), individuals with elevated Lp(a) levels (median, 87 mg/dL [218 nmol/L]; n=12) demonstrated an increase in lipid species, particularly diacylglycerols (DGs) and lysophosphatidic acid (LPA). DG and the LPA precursor lysophosphatidylcholine were enriched in the Lp(a) fraction. Ex vivo stimulation with DG(40:6) demonstrated a significant upregulation in proinflammatory pathways related to leukocyte migration, chemotaxis, NF-κB (nuclear factor kappa B) signaling, and cytokine production. Functional assessment showed a dose-dependent increase in the secretion of IL (interleukin)-6, IL-8, and IL-1β after DG(40:6) and DG(38:4) stimulation, which was, in part, mediated via the NLRP3 (NOD-like receptor family pyrin domain containing 3) inflammasome. Conversely, LPA-stimulated monocytes did not exhibit an inflammatory phenotype. Furthermore, activation of monocytes by DGs and LPA increased their transendothelial migratory capacity. Human atherosclerotic plaques from patients with high Lp(a) levels demonstrated colocalization of Lp(a) with M1 macrophages, and an enrichment of CD68+IL-18+TLR4+TREM2+resident macrophages and CD68+CASP1+IL-1B+SELL+inflammatory macrophages compared with patients with low Lp(a). Finally, potent Lp(a)-lowering treatment (pelacarsen) resulted in a reduction in specific circulating DG lipid subspecies in patients with cardiovascular disease with elevated Lp(a) levels (median, 82 mg/dL [205 nmol/L]).CONCLUSIONS:Lp(a)-associated DGs and LPA have a potential role in Lp(a)-induced monocyte inflammation by increasing cytokine secretion and monocyte transendothelial migration. This DG-induced inflammation is, in part, NLRP3 inflammasome dependent.
peripheral vascular disease,hematology